RUNX3 is a potent tumor suppressor in gastric cancer 66 and we demonstrated that lung cancer patients harboring the RUNX3-CLDN1 axis have better overall survival, suggesting RUNX3 may be a tumor suppressor in lung cancer. Here, CLDN1 is linked to lung carcinoma.